5-Methoxytryptophan alleviates atrial structural remodeling in ibrutinib-associated atrial fibrillation.

Shuai, Wei; Peng, Bo; Zhu, Jun; Kong, Bin; Fu, Hui; Huang, He

Shuai, Wei; Peng, Bo; Zhu, Jun; Kong, Bin; Fu, Hui; Huang, He.

Afiliação

Shuai W; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, PR China.
Peng B; Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei, PR China.
Zhu J; Hubei Key Laboratory of Cardiology, Wuhan, 430060, Hubei, PR China.
Kong B; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, PR China.
Fu H; Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei, PR China.
Huang H; Hubei Key Laboratory of Cardiology, Wuhan, 430060, Hubei, PR China.

Heliyon ; 9(9): e19501, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37810107

Palavras-chave

5-Methoxytryptophan; Atrial fibrillation; Ibrutinib; PI3K-Akt signaling; Structural remodeling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google